Original Articles

Targeted SERCA2a Gene Expression Identifies Molecular Mechanism and Therapeutic Target for Arrhythmogenic Cardiac AlternansCLINICAL PERSPECTIVE

Michael J. Cutler, Xiaoping Wan, Kenneth R. Laurita, Roger J. Hajjar, David S. Rosenbaum
https://doi.org/10.1161/CIRCEP.109.863118
Circulation: Arrhythmia and Electrophysiology. 2009;2:686-694
Originally published December 15, 2009

Jump to

Abstract

Background— Beat-to-beat alternans of cellular repolarization is closely linked to ventricular arrhythmias in humans. We hypothesized that sarcoplasmic reticulum calcium reuptake by SERCA2a plays a central role in the mechanism of cellular alternans and that increasing SERCA2a gene expression will retard the development of cellular alternans.

Methods and Results— In vivo gene transfer of a recombinant adenoviral vector with the transgene for SERCA2a (Ad.SERCA2a) was performed in young guinea pigs. Isolated myocytes transduced with Ad.SERCA2a exhibited improved sarcoplasmic reticulum Ca2+ reuptake (P<0.05) and were markedly resistant to cytosolic calcium alternans (P<0.05) under repetitive constant action potential clamp conditions (ie, when alternation of action potential duration was prevented), proving that sarcoplasmic reticulum Ca2+ cycling is an important mechanism in the development of cellular alternans. Similarly, SERCA2a overexpression in the intact heart demonstrated significant resistance to alternation of action potential duration when compared with control hearts (heart rate threshold, 484±25 bpm versus 396±11 bpm, P<0.01), with no change in action potential duration restitution slope. Importantly, SERCA2a overexpression produced a 4-fold reduction in susceptibility to alternans-mediated ventricular arrhythmias (P<0.05).

Conclusions— These data provide new evidence that sarcoplasmic reticulum Ca2+ reuptake directly modulates susceptibility to cellular alternans. Moreover, SERCA2a overexpression suppresses cellular alternans, interrupting an important pathway to cardiac fibrillation in the intact heart.

Received March 7, 2009; accepted September 23, 2009.

Although ventricular arrhythmias are the most common cause of cardiovascular mortality, the mechanisms responsible for triggering electric instability in the heart are poorly understood. Cardiac alternans is a repetitive beat-to-beat fluctuation of cellular repolarization that is closely associated with ventricular arrhythmias and sudden cardiac death in a wide variety of experimental23,36,43 and clinical33,40 conditions. It is clear that alternans arises from alternation of action potential duration (APD-ALT) at the level of the single cell,12,17 and it has been proposed that APD-ALT arises secondarily from an effect on calcium-sensitive electrogenic sarcolemmal currents during cytosolic calcium alternans (Ca-ALT)9,42,7,13 Therefore, understanding the cellular and molecular basis for Ca-ALT can provide important and novel insights into mechanisms of ventricular arrhythmias.

Clinical Perspective on p 686

It is generally accepted that cellular alternans occurs when the heart rate (HR) exceeds capabilities of the cardiac myocyte to cycle calcium on a beat-by-beat basis. This hypothesis predicts that during steady state (ie, resting HR), the amount of Ca2+ released from the sarcoplasmic reticulum (SR) to initiate cardiac contraction must be matched by the Ca2+ reclaimed from the cytoplasm, primarily by SERCA2a. Any sustained disturbance in the myocyte’s ability to load or release SR Ca2+ presumably leads to the development of Ca2+ alternans. For example, instabilities of SR Ca2+ release through the RyR release channel either with7 or without13,27 fluctuations of SR Ca2+ content has been argued as a mechanism for cellular alternans. An alternative and equally compelling hypothesis implicates impaired SR reuptake in the mechanism of Ca-ALT.43 However, the specific SR Ca2+ cycling proteins underlying the molecular basis for cellular alternans are unknown. Recent data from our laboratory provide important insight into the molecular basis for cellular alternans. In particular, cardiac myocytes that are most susceptible to APD-ALT exhibit reduced expression of the SERCA2a and delayed SR Ca2+ reuptake42,19 These findings led us to hypothesize in the present study that SERCA2a function plays a critical role in the initiation of cellular alternans.

Identification of a molecular basis for cardiac alternans has been challenging because of difficulties in distinguishing experimentally the complex interactions between sarcolemmal and sarcomeric ionic fluxes using relatively nonspecific pharmacological probes. However, gene transfer techniques can be used to alter the expression of single proteins, and, in this way, disease mechanisms can be elucidated and potential therapeutic targets identified. Therefore, to test our hypothesis that SERCA2a function is an important mechanism in the initiation of cellular alternans, we performed in vivo gene transfer of Ad.SERCA2a.GFP in the guinea pig heart. Overexpression of SERCA2a significantly inhibited cellular alternans and susceptibility to ventricular arrhythmias in the intact beating guinea pig heart. These data establish a molecular mechanism for arrhythmogenic cardiac alternans. Specifically, enhancement of SERCA2a gene expression will diminish susceptibility to cellular alternans, thereby interrupting an important pathway to cardiac fibrillation in the intact heart.

Methods

In Vivo Gene Delivery

Recombinant adenoviral vectors were used with cytomegalovirus-driven expression cassettes for SERCA2a (Ad.SERCA2a) with a second cassette in each adenovirus containing GFP substituted for E1 by means of homologous recombination as previously described.6 Control adenoviral vectors were used with cytomegalovirus-driven expression cassettes for GFP (Ad.GFP) or β-galactosidase (Ad.β-gal).

Experiments were carried out in accordance with the United States Public Health Service guidelines for the care and use of laboratory animals. In vivo gene transfer was performed using a modified cross-clamping method.4 Briefly, animals were anesthetized (Ketamine, Xylazine, Acepromazine, and Atropine) and mechanically ventilated (2.0-cc tidal volume at 50 cycles per minute) via a tracheostomy (18-gauge tube). An anterior thoracotomy was performed, and the pulmonary artery and aorta were isolated. A 27-gauge catheter was advanced from the apex to the aortic root. Subsequently, the aorta and pulmonary artery were cross-clamped for 50 to 60 seconds, and the virus solution (1×1012 particle/mL Ad.SERCA2a.GFP, n=7; 1×1012 particle/mL Ad.GFP, n=5; or 1.2×1011 particle/mL Ad.β-gal, n=3; plus 75 μg/mL of nitroglycerin) was injected. The animals were placed on a heating pad (42°C), the chest was closed, and intrathoracic air was evacuated. Animals were extubated on spontaneous breathing and closely observed until fully awake.

Efficiency of In Vivo Gene Transfer

Qualitative Assessment of Transduction Efficiency

Seventy-two hours after gene transfer with β-galactosidase, animals (n=3) were euthanized with pentobarbital. The heart was rapidly removed, flushed with phosphate-buffered saline, and transversely sliced into 3 pieces used for x-gal staining.8 This procedure was performed to assess the regional distribution and homogeneity of gene delivery in the intact heart.

Quantitative Assessment of Transduction Efficiency

Seventy-two hours after gene transfer, myocytes isolated from the left ventricular free wall were examined by fluorescence microscopy to calculate transduction efficiency. Efficiency is reported as the percentage of all myocytes in the microscope field that fluoresced green.

SERCA2a Protein Expression

Myocytes isolated from the transmural left ventricular free wall of both SERCA2a transduced hearts and age-matched control hearts, as previously described, were used for Western blotting to determine the relative expression levels of SERCA2a.42 Cardiac homogenates (10 μg for SERCA2) were separated on SDS-PAGE and transferred to polyvinylidene diflouride membranes. Blots were probed with rabbit anti-SERCA antibody (Dr Periasamy, Ohio State University). They were then treated with horseradish peroxidase-conjugated anti-rabbit antibody. Protein bands were quantified using ImageQuant software.

Isolated Myocyte Studies

Seventy-two hours after in vivo gene transfer, isolated myocyte electrophysiological studies were performed. Membrane voltage and intracellular calcium were measured simultaneously using the perforated patch technique and the fluorescent Ca2+ indicator indo-1AM. Myocytes transduced with Ad.SERCA2a and Ad.GFP (ie, control) were confirmed using GFP fluorescence. Because there were no statistical differences in calcium cycling characteristics and alternans susceptibility between myocytes isolated from untreated hearts and Ad.GFP transduced hearts, data are presented as a combined control group.

Patch-Clamp Recordings

The amphotericin perforated patch technique was used to obtain whole-cell recordings of membrane voltage under current-clamp conditions as described previously.3 Briefly, the cells were bathed in a chamber continuously perfused with Tyrode solution composed of (mmol/L) NaCl 137, KCl 5.4, CaCl2 2.0, MgSO4 1.0, glucose 10, HEPES 10, pH to 7.35 with NaOH. Patch pipettes were pulled from borosilicate capillary glass and lightly fire-polished to resistance 0.9 to 1.5 mol/LΩ when filled with electrode solution composed of (mmol/L) aspartic acid 120, KCl 20, NaCl 10, MgCl2 2, HEPES 5, and 240 μg/mL of amphotericin-B (Sigma, St Louis, Mo), pH7.3. A gigaseal was rapidly formed. Typically, 10 minutes later, amphotericin pores lowered the resistance sufficiently to current-clamp the cells. Myocytes were paced using a 1.5 to 2 diastolic threshold, 5-ms current pulse. Experiments were performed at 30°C. Command and data acquisition were operated with an Axopatch 200B patch-clamp amplifier controlled by a personal computer using a Digidata 1200 acquisition board driven by pCLAMP 7.0 software (Axon Instruments, Foster City, Calif).

Calcium Transient Recordings

Intracellular Ca2+ transients were measured simultaneously using the fluorescent Ca2+ indicator indo-1AM as described previously.18 Cells were loaded with indo-1AM by incubating them in Tyrode containing indo-1AM (2 μmol/L) (Molecular Probes) and 0.025% (wt/wt) Pluronic F-127 (Molecular Probes) for 30 minutes at room temperature. The intracellular indo-1 was excited at 355 nm. Fluorescence emitted at 405 and 485 nm was collected by 2 matched photomultiplier tubes. Data were filtered at 200 Hz and sampled at 1 kHz. The ratio of the intensity of fluorescence emitted at 405 nm over that at 485 nm was calculated after subtraction of background fluorescence as described previously.16 The emission field was restricted to a single cell with the aid of an adjustable window. To determine intracellular calcium concentration, the ratiometric calcium transients were calibrated using the techniques developed by Grynkeiwicz et al.10 The calibration parameters, Rmin and Rmax, were obtained from isolated myocytes with either a modified calcium-free, Rmin (n=8) or a calcium-saturated, Rmax (n=8) Tyrode solution. The modified Rmin solution contained (mM) 132 KCl, 1.0 MgCl2, 10 EGTA, 10 HEPES, 0.05 4-bromo-A-23817; pH 7.05. The modified Rmax solution contained (mM) 132 KCl, 1.0 MgCl2, 2 CaCl2, 10 HEPES, and 10 BDM; pH 7.05. The dissociation constant (Kd) was 250 nM and β was 2.5.(8) Calcium concentrations were calculated using the following standard calibration equations10: [Ca2+]i=Kd*β* ([R−Rmin]/[Rmax−R]).

Stimulation Protocol

Myocytes were stimulated at a baseline stimulation rate of 150 beats per minute (bpm). After a period of stimulation to establish steady state, measurements were made for the subsequent 20 beats. This protocol was repeated at progressively faster rates until 1:1 capture was lost.

Whole Heart Studies

Whole heart electrophysiological studies were performed in Ad.SERCA2a and control hearts. Because there were no statistical differences in alternans magnitude, alternans HR threshold, and arrhythmia susceptibility between untreated control (n=5) and sham-operated Ad.GFP controls (n=3), data are presented as a combined control group (n=8). Isolated hearts were Langendorff-perfused with oxygenated (95% O2, 5% CO2) Tyrode solution (in mmol/L: NaCl 130, NaHCO3 25.0, MgSO4 1.2, KCl 4.75, dextrose 5.0, CaCl2 1.25, pH 7.40, 32°C), and the endocardial surface was eliminated by a cryoablation procedure described previously.25 This model is highly optimal to study alternans after gene transfer because our current gene delivery technique provides greatest gene transfer to the epicardium (Figure 1A).

Figure1

Figure 1. Gene transfer efficiency 72 hours after in vivo viral transduction. A, Example of X-gal-stained cross section of guinea pig ventricles excised 4 days after Ad.β-gal exposure. B, Myocytes isolated from left ventricular free wall of guinea pig heart transduced with Ad.SERCA2.GFP. Fluorescent image shows the GFP transduction efficiency around 30%. C, Example of protein expression. In vivo viral transduction increased SERCA2a expression compared with control (P<0.05).

High-resolution optical action potentials were recorded from the anterior surface of the left ventricle using the voltage sensitive dye di-4-ANEPPS (15 μmol/L), as previously described. Cardiac alternans is induced by stepwise decrements (10 ms) in pacing cycle length (CL) but was not measured until 30 seconds after the decrement in rate to ensure its stability.41 CL was decremented until failure to capture the preparation or the development of a ventricular arrhythmia.23

Data Analysis

Isolated Myocytes

APD was measured at 90% repolarization (APD90). Ca2+ transient parameters were defined as described previously19,42: Diastolic Ca2+ was defined as cytosolic Ca2+ level just before the onset of the Ca2+ transient or just before the action potential upstroke in the cases in which there was no obvious Ca2+ transient. Amplitude of intracellular Ca2+ transient was calculated from the difference between peak and diastolic Ca2+. The duration of intracellular Ca2+ transient was measured as the onset of the Ca2+ transient to the point of time when the transient decayed 90% of its amplitude. To further quantify the rate of reuptake of intracellular Ca2+, the decay portion of the Ca2+ transient (from 30% to 100% of decline phase) was fit to a single exponential function whose time constant, τ, was used to measure Ca2+ decay.

APD-ALT was measured by calculating the difference in action potential duration (APD90) on 2 consecutive beats and was defined to be present when APD-ALT exceeded 10 ms, as previously described.26 Ca-ALT was measured by calculating the difference in amplitude on 2 consecutive beats and was defined to be present when Ca-ALT exceeded 10% of Ca2+ transient amplitude, as described previously.19

Whole Heart

APD-ALT was defined as the difference in APD between 2 consecutive beats.29,25 The alternans-HR relation was plotted as the magnitude of APD-ALT as a function of HR. A leftward or rightward shift in this relation (ie, development of alternans at lower or higher HRs) indicates greater or reduced susceptibility to alternans, respectively. The slowest HR that induces alternans was defined as the threshold HR for alternans.29,25,26 Activation time, repolarization time, and APD were measured from optically recorded action potentials using automated algorithms that have been validated extensively.25,26,32 Dynamic APD restitution was measured by plotting APD as a function of DI measured during periods of rapid pacing used to promote alternans.29 Arrhythmia susceptibility was determined using a standardized ramp pacing protocol starting at 300 ms (200 bpm) with stepwise 10-ms decrements in pacing CL until failure of 1/1 capture or the induction of a ventricular arrhythmia.29 Arrhythmias were defined as a tachyarrhythmia sustained for >30 seconds after pacing was halted.

Statistical Analysis

Statistical analyses of data were performed using Sigmastat (SPSS, Inc, Chicago, Ill). Statistical differences were assessed with Student t test and Fisher exact test as appropriate. When unequal variance was detected during normality testing, the Wilcoxon rank-sum test was used. Results are expressed as mean±SEM.

Results

Efficiency of Transgene Expression

Figure 1 shows transduction efficiency 72 hours after in vivo gene transfer. Panel A illustrates a representative example of an X-gal-stained cross section of guinea pig ventricles after Ad.β-gal gene transfer. The blue stain demonstrates relatively homogeneous gene transfer throughout the epicardium and extending through approximately two thirds of the transmural wall, leaving the endocardial-most myocardium unstained. Panel B illustrates myocytes isolated from the left ventricular free wall of a guinea pig heart transduced with Ad.SERCA2a. The fluorescent image shows GFP transduction efficiency (green cells), which averaged 29±2%. Panel C demonstrates that SERCA2a (n=3) gene transfer significantly increased SERCA2a protein expression in the left ventricular free wall by 37±7% (P<0.05), compared with control (n=3).

Effect of SERCA2a Gene Transfer on Calcium Transient Characteristics

Intracellular Ca2+ transients and action potentials were induced under current clamp-conditions at a pacing rate of 150 bpm at 30°C and were compared between isolated control myocytes and myocytes transduced with Ad.SERCA2.GFP 72 hours after in vivo gene transfer. As shown in Figure 2A, SERCA2a overexpression (right), produced, as expected, accelerated reuptake of cytosolic Ca2+ as measured by the time constant, τ, of Ca2+ transient recovery. Also, Ca2+ transient amplitude was significantly increased (Figure 2B) and diastolic Ca2+ was not statistically different between Ad.SERCA2a and control myocytes. Despite differences in Ca2+ transient characteristics, APD was not significantly changed by SERCA2a overexpression (Figure 2A). As expected, these data demonstrated that in vivo transduction of Ad.SERCA2a improved SR Ca2+ reuptake accompanied by larger Ca2+ transients and faster rates of [Ca2+]i decline, confirming that this model of SERCA2a overexpression produces a meaningful effect on SR calcium cycling.

Figure2

Figure 2. Ca2+ cycling characteristics. Intracellular Ca transients and action potentials were induced under current-clamp conditions at a pacing rate of 150 bpm at 30°C. A, Traces were recorded from a control myocyte (left) and an Ad.SERCA2a myocyte (right). The Ca cycling characteristics in the Ad.SERCA2a myocyte were different from those in the control myocyte as illustrated by faster Ca reuptake (smaller Ca decay time constant (τ), shorter Ca transient duration) and greater Ca release (greater Ca amplitude). However, diastolic [Ca2+] and APDs were not statistically different between these cells. B, Summary data from Ad.SERCA2a myocytes (n=6) and control myocytes (n=6) are shown. As compared with control myocytes, Ad.SERCA2a myocytes exhibited markedly faster Ca reuptake (38% faster τ) and greater Ca release (43% larger amplitude).

Effect of SERCA2a Gene Transfer on Susceptibility to Cellular Alternans in Isolated Myocytes

APD-ALT and Ca-ALT were measured simultaneously as stimulus rate was progressively increased. Figure 3A shows representative examples of action potential and Ca2+ transient recordings obtained from an Ad.SERCA2a myocyte and a control myocyte. Traces recorded from 2 consecutive beats are superimposed to illustrate alternans. APD-ALT and Ca-ALT were induced as stimulation rate was increased to 200 bpm in control myocytes. In contrast, alternans could not be initiated even at a pacing rate of 240 bpm in the Ad.SERCA2a myocyte. Data from control myocytes (n=9) and Ad.SERCA2a myocytes (n=11) are summarized in Figure 3B. As expected, the magnitude of APD-ALT increased in a rate-dependent fashion. However, in contrast to control myocytes, Ad.SERCA2a myocytes exhibited a significant rightward shift if the APD-ALT-HR relationship with greatly attenuated APD-ALT magnitude, indicating induction of marked resistance to APD-ALT with SERCA2a overexpression. The inset of Figure 3B shows that under current-clamp conditions, the threshold stimulation rate for both APD-ALT and Ca-ALT in control myocytes (n=9) is significantly lower than in Ad.SERCA2a myocytes (n=9).

Figure3

Figure 3. SERCA2a overexpression suppresses cellular alternans in isolated myocytes. A, Representative examples of action potential and Ca transient recordings obtained from an Ad.SERCA2a myocyte and control myocyte. Traces recorded from 2 consecutive beats are superimposed to illustrate alternans. APD-ALT and Ca-ALT were induced as stimulation rate was increased to 200 bpm in the control myocyte, whereas alternans was not initiated until a pacing rate of 375 bpm in the Ad.SERCA2a myocyte. B, SERCA2a overexpression increased alternans threshold and decreased alternans magnitude in isolated myocytes. Plot of pacing rate versus magnitude of APD-ALT from summary data of control myocytes (n=9) and Ad.SERCA2a myocytes (n=11) shows that the magnitude of APD-ALT increased as pacing rate increased, and the magnitude of APD-ALT was consistently greater in control myocytes compared with Ad.SERCA2a myocytes. Inset shows that under current-clamp conditions, the threshold stimulation rate for both APD-ALT and Ca-ALT in control myocytes (n=9) is significantly lower than in Ad.SERCA2a myocytes (n=9) (265±17 bpm and 349±22 bpm, respectively, P<0.01).

Figure 4 illustrates that SERCA2a overexpression imparts significant resistance to cellular alternans even under constant action potential (AP) clamp conditions (ie, when APD-ALT is prevented). The top tracing is a representation of the AP clamp protocol (voltage command). In this example, Ca2+ transients recorded under constant AP clamp conditions at a stimulation rate of 200 bpm are shown in the middle (Ad.SERCA2a myocyte) and in the bottom (control myocyte). At this stimulation rate, Ca-ALT was clearly present in control myocytes but not in Ad.SERCA2a myocytes. The 40% increase (P<0.01) in the HR threshold required to induce Ca-ALT under AP clamp conditions (Figure 4B) reaffirmed that overexpression of SERCA2a suppressed Ca-ALT as a result of its effects on cellular Ca2+ cycling rather than any indirect effects of the action potential.

Figure4

Figure 4. SERCA2a overexpression increased alternans threshold even under constant AP clamp conditions. A, Ca-ALT occurred under constant AP clamp conditions. The top trace is AP clamp protocol (voltage command). In this example, Ca transients recorded under constant AP clamp conditions at stimulation rate of 200 bpm are shown in the middle (Ad.SERCA2a myocyte) and in the bottom (control myocyte). At this stimulation rate, Ca transients alternate in the control myocyte but not in the Ad.SERCA2a myocyte. B, The differences in threshold for Ca-ALT between control (n=12) and Ad.SERCA2a myocytes (n=4) remained even under constant AP clamp conditions (254±11 bpm and 352±26 bpm, respectively, P<0.01).

Effect of SERCA2a Gene Transfer on Susceptibility to Cellular Alternans in the Intact Beating Heart

APD alternans was measured as pacing rate was progressively increased in the Langendorff-perfused whole heart. Figure 5 demonstrates that overexpression of SERCA2a increased alternans threshold and decreased alternans magnitude in the whole heart. The plot of pacing rate versus magnitude of APD-ALT from summary data of control (n=8) and Ad.SERCA2a (n=4) transduced hearts shows that the magnitude of APD-ALT increased as pacing rate increased, and the magnitude of APD-ALT was consistently greater in control compared with Ad.SERCA2a hearts. The inset shows that the HR threshold for APD-ALT in control hearts is significantly lower than in Ad.SERCA2a hearts (P<0.01). Also, as expected, conduction velocity was not different between Ad.SERCA and control hearts (41.8±6.4 cm/s versus 32.6±2.5 cm/s; P=0.24).

Figure5

Figure 5. SERCA2a overexpression increased alternans threshold and decreased alternans magnitude in the whole heart. Plot of pacing rate versus magnitude of APD-ALT from Ad.SERCA2a, control Langendorff-perfused whole hearts shows that the magnitude of APD-ALT increased as pacing rate increased, and the magnitude of APD-ALT was consistently greater in control (n=8) hearts compared with Ad.SERCA2a (n=4) hearts. Inset shows that the threshold pacing rate for APD-ALT in control hearts is significantly lower than Ad.SERCA2a hearts (396±11 bpm and 484±25 bpm, respectively, P<0.01). *P≤0.01, Ad.SERCA2a versus control.

In addition to calcium cycling mechanisms, APD restitution has been implicated in the mechanism of APD-ALT. However, as shown in Figure 6, there was no difference in APD restitution (average APD restitution from all experiments are plotted) between control hearts and Ad.SERCA2a hearts. Moreover, derived metrics of restitution properties such as maximum restitution curve slope and predicted onset HR for APD-ALT failed to predict the marked reduction in susceptibility to APD-ALT seen SERCA2a-treated hearts.

Figure6

Figure 6. SERCA2a overexpression does not change dynamic APD restitution in the whole heart. Plot of mean dynamic APD restitution shows no difference between control and Ad.SERCA2a hearts. Inset shows that the actual threshold pacing rate for alternans was lower in control versus Ad.SERCA2a hearts, yet there was no significant difference in maximum APD restitution slope or the predicted alternans thresholds.

Effect of SERCA2a Gene Transfer on Susceptibility to Ventricular Arrhythmia

Figure 7A shows representative optical action potential tracings from control and Ad.SERCA2a transduced hearts. In the control heart, beat-to-beat alternation of APD is seen immediately preceding the onset of ventricular fibrillation. This was a consistent finding in all control preparations. Conversely, in the heart transduced with Ad.SERCA2a, the identical stimulation sequence fails to induce cellular alternans or ventricular fibrillation. Figure 7B demonstrates that SERCA2a overexpression reduced susceptibility to alternans-mediated ventricular arrhythmias compared with control (P<0.05).

Figure7

Figure 7. SERCA2a overexpression suppresses pacing-induced ventricular arrhythmias. A, Representative optical action potential tracing from a control heart at a pacing CL of 140 ms demonstrating APD-ALT immediately preceding the onset of ventricular fibrillation. Conversely, in an Ad.SERCA2a heart at an even faster pacing CL (130 ms) there is little to no APD-ALT and the absence of an arrhythmia. B, Using a ramp pacing protocol, 8 of 8 controls had either ventricular tachycardia (VT) or ventricular fibrillation (VF). In contrast, only 1 of 4 Ad.SERCA2a hearts developed a ventricular arrhythmia (P<0.05). *P<0.05, Ad.SERCA2a versus control.

In summary, these data show that overexpression of SERCA2a inhibited cellular alternans in both isolated myocytes and the whole heart, suggesting that SERCA2a function plays an important role in the initiation of cellular alternans. Furthermore, SERCA2a overexpression suppresses alternans-mediated ventricular arrhythmias in the intact beating heart.

Discussion

Previously, we25 and others30 demonstrated that cellular alternans is a mechanistic precursor to ventricular fibrillation in the mammalian heart. Presumably in diseased hearts, by lowering the HR threshold for T-wave alternans, vulnerability to ventricular fibrillation increases. Therefore, identifying molecular mechanisms that modulate susceptibility to alternans could provide important clues to novel triggers of electric instability in the heart. The primary findings of this investigation are (1) overexpression of SERCA2a significantly inhibited cellular alternans in both isolated myocytes and the whole heart, and (2) SERCA2a overexpression suppresses alternans-mediated ventricular arrhythmias in the intact beating heart. These data support our hypotheses that SR calcium cycling plays a causative role in cellular alternans, SERCA2a function specifically plays an important role in the initiation of cellular alternans, and SERCA2a is a potentially novel molecular therapeutic target for the treatment of ventricular arrhythmias.

Sarcoplasmic Reticulum Ca2+ Cycling Underlies Mechanism of Cellular Alternans

There are 2 major hypotheses that have been proposed to explain the development of cellular alternans: (1) the APD restitution hypothesis, largely secondary to alternating sarcolemmal currents, and (2) the calcium cycling hypothesis, which states that alternans occurs when HR exceeds the capacity of the myocyte to cycle calcium. Theoretical models suggest that APD alternans occurs when the slope of the APD restitution curve exceeds unity. Moreover, a variety of sarcolemmal currents such as Ito,21 ICa,18 and IKr22 can exhibit alternating-type activity. Although the restitution hypothesis provides a very useful theoretical framework for understanding the dynamics of APD alternans, there is also considerable experimental evidence that does not support the restitution hypothesis.29,9 By using in vivo gene transfer to selectively increase SERCA2a expression, the present study shows that selective enhancement of SR Ca2+ reuptake significantly inhibits both Ca-ALT and Vm-ALT. These findings indicate a causative role of SR Ca2+ cycling in the mechanism of Vm-ALT. However, it is also possible, based on theoretical predictions, that SERCA2a overexpression could have altered sarcolemmal ionic currents and that these alterations could alter susceptibility to cellular alternans.39 In the present investigation, we distinguished mechanisms arising from intracellular Ca2+ handing versus sarcolemmal ionic currents in isolated myocytes by using a nonalternating action potential (AP) clamp. Moreover, because AP clamp is not possible in the intact heart, we compared APD restitution properties of SERCA2a with controls, particularly because APD restitution has been used as an index of the extent to which sarcolemmal ionic currents drive cellular alternans. Interestingly, suppression of Ca-ALT under AP clamp conditions in myocytes (Figure 4) and the lack of a change in APD restitution in whole hearts overexpressing SERCA2a (Figure 6) provide important new evidence that calcium cycling properties can underlie susceptibility to alternans without any involvement of APD restitution. Also, our data are consistent with previous observations that inhibiting Ca2+ cycling by blocking the RyR, ICa or by depleting SR Ca2+ stores with caffeine eradicates Vm-ALT.11,34,35 Furthermore, the seminal observations of Chudin et al3 and our laboratory42 that Ca-ALT is similarly induced under current-clamp (where Vm-ALT occurs) and voltage-clamp (ie, where Vm-ALT is prevented) conditions proved that Ca-ALT is not dependent on Vm-ALT and strongly supported the notion that cellular alternans arises from SR Ca2+ cycling.

Role of SERCA2a in Molecular Mechanism of Cellular Alternans

Despite the importance of Ca-ALT on the development of APD-ALT, the specific Ca2+ cycling proteins responsible for alternans were based primarily on predictions from theoretical models and experimental evidence relying on associations between impaired SR calcium handling, diminished expression of calcium handling proteins, and susceptibility to cellular alternans. 42,43,19 The advantage to using in vivo gene transfer targeting a single gene, as in the present study, is the ability to demonstrate a causal relationship between a single protein and the development of cellular alternans. Previously, we suggested that impaired SR Ca2+ reuptake may represent a mechanism to initiate alternans.42 For example, when compared with epicardial myocytes, endocardial myocytes had reduced SERCA2a expression and reduced ability to reuptake cytosolic Ca2+ into the SR. As such, we hypothesized that reduced SERCA2a expression may underlie the increased susceptibility of endocardial myocytes to develop cellular alternans. In the current investigation, we performed in vivo gene transfer using a modified aorto-pulmonary artery cross-clamp technique to achieve a 37% increase in SERCA2a. This resulted in improved SR Ca2+ reuptake (ie, accelerated Ca2+ transient decay and increased Ca2+ transient amplitude) and inhibited cellular alternans in both isolated myocytes and the whole heart. Our results are consistent with the recent observations of Xie et al44 that adenoviral-mediated SERCA2a overexpression in cultured rabbit ventricular myocytes suppresses Ca-ALT and the findings that the SERCA2a inhibitor thapsigargin increases susceptibility to cellular alternans.15

Though this investigation demonstrates with a high degree of specificity that the SERCA2a protein directly affects susceptibility to cellular alternans, these data do not rule out other synergistic or complementary molecular mechanisms. For example, observations from both experimental and theoretical models have demonstrated a steep dependence of SR Ca2+ release on SR Ca2+ load as a mechanism for the development of Ca2+ alternans. 7,43 Diaz et al7 used an innovative albeit nonphysiological stimulation protocol to induce Ca-ALT without pharmacological inhibition of RyR (thereby avoiding nonselective drug effects). Ventricular myocytes were repetitively voltage-clamped below the activation voltage for ICa. The resulting weak CICR produced desynchronized RyR release, which dramatically steepened the relationship (feedback gain) between SR Ca2+ content (ie, luminal Ca2+) and the subsequent SR Ca2+ release. These subcellular conditions highly favored the development of Ca-ALT dynamics that are dependent on beat-to-beat alternation of SR Ca2+ content. Moreover, instabilities of SR Ca2+ release can also lead to Ca-ALT. For example, using metabolic inhibition in cat atrial and ventricular myocytes to inhibit RyR phosphorylation, Huser et al13 reported Ca-ALT without beat-to-beat fluctuations in SR content, suggesting that refractory-like properties of RyR can produce alternating open probabilities of the channel irrespective of SR Ca load. Also, Picht et al27 recently demonstrated that beat-to-beat variations in recovery from inactivation of the RyR without variation in SR Ca2+ load can produce Ca-ALT. In contrast, Lehnart et al20 recently demonstrated that Calstabin (FKBP12.6) deficiency increases susceptibility to the development of APD-ALT by destabilizing RyR.

Interestingly, in the present study, inhibition of cellular alternans in the intact heart occurred despite modest adenoviral transduction efficiency on a cellular scale (29±2% of myocytes). Importantly, our method of virus delivery produced spatially homogeneous transgene expression in essentially all regions of the heart that were readily accessible for detailed electrophysiological phenotyping using high-resolution optical mapping of the intact heart. Moreover, this study demonstrates that complete gene transfer is not required to produce an important electrophysiological phenotype. One explanation for this finding is that electrotonic interactions between neighboring cells via gap junctions act to homogenize membrane potential across cells. For example, reduction in Ca-ALT and therefore APD-ALT in a cell transduced with Ad.SERCA2a is expected to attenuate APD-ALT in a nontransduced neighboring cell. This is supported by the observation that the magnitude of SERCA2a suppression of cellular alternans in isolated myocytes (Figure 3B) is greater than in whole hearts (Figure 5). These findings have practical clinical implications, suggesting that strategies designed to target SERCA2a gene expression in patients probably does not need to achieve high transduction efficiency for a desirable clinical benefit to be realized. However, it is likely that gene delivery does need to be spatially homogenous throughout the myocardium because lack of homogeneity could produce electrophysiological heterogeneities that are potentially arrhythmogenic. In fact, the completion of a phase 1/2 clinical trial of Myocardial Delivery of AAV1/SERCA2a in Subjects with Advanced Heart Failure has been shown to have an acceptable safety profile in the patients.37

Enhanced SERCA2a Gene Expression Interrupts a Pathway to Arrhythmogenesis

The present study demonstrates that targeted overexpression of SERCA2a reduces cellular alternans and susceptibility to inducible arrhythmias in the intact heart. Previously, we demonstrated a mechanistic link between cellular alternans and the genesis of ventricular arrhythmias.25 Specifically, discordant alternans (ie, repolarization alternans occurring with opposite phase between neighboring cells) alters the spatial organization of repolarization across the ventricle by markedly amplifying preexisting heterogeneities of repolarization in the heart, producing a substrate prone to conduction block and reentrant arrhythmogenesis. Therefore, suppression of cellular alternans in the present study decreases the likelihood for amplifying heterogeneity of repolarization, conduction block, and thus, ventricular arrhythmias. This observation is consistent with the clinical observation that patients with heart failure with a negative T-wave alternans test (the surface ECG representation of cellular alternans) are remarkably resistant to sudden cardiac death.38 Furthermore, our data are supported by the observations of del Monte et al6 and Prunier et al28 that overexpression of SERCA2a suppressed ventricular arrhythmias in both rat and porcine models of ischemia-reperfusion (Ca2+ overload). Specifically, ischemia-reperfusion increases diastolic calcium and has been linked to delayed afterdepolarizations and triggered arrhythmias. The authors speculate that enhanced SR calcium reuptake with SERCA2a overexpression decreases diastolic Ca2+, thus decreasing the incidence of delayed afterdepolarizations and triggered arrhythmias. Additionally, Prunier et al28 speculated that a possible mechanism by which SERCA2a overexpression suppressed the development of ventricular arrhythmias in ischemia-reperfusion is by inhibiting cellular alternans.

Targeted overexpression of SERCA2a as an antiarrhythmic therapy has a potential advantage in that this approach does not target sarcolemmal K+ channels; a strategy known to cause QT interval prolongation and proarrhythmia. SERCA2a gene transfer did not prolong repolarization in our studies. However, it is possible that overexpression of SERCA2a could be arrhythmogenic because enhanced SR calcium load could increase susceptibility to spontaneous SR calcium release and delayed afterdepolarization-mediated triggered arrhythmias. However, in the present study we saw no evidence of spontaneous arrhythmias or delayed afterdepolarizations. This may be explained by the modest degree of SERCA2a overexpression seen in this study.

Pathophysiological Implications

Our data have important clinical implications. T-wave alternans has been observed in patients with heart failure and is an important marker of risk for sudden cardiac death.24,31,38 Moreover, altered calcium cycling is a common observation in heart failure1 probably caused by reduced SERCA2a expression (impaired SR Ca2+ reuptake), increased phosphorylation of RyR (impaired SR Ca2+ release), and/or altered NCX expression/function. The current investigation suggests that SERCA2a dysfunction can play an important role in modulating susceptibility to cellular alternans, providing a potential link between mechanical and electric dysfunction in the failing heart. To our knowledge, our data are the first to support a direct causal relationship between SERCA2a function and susceptibility to cellular alternans in the intact heart. Importantly, SERCA2a overexpression has been shown to reverse failure-induced changes in contractility.5 Moreover, inhibition of cellular alternans produces a myocardial substrate that is resistant to reentry and fatal arrhythmias. As such, in vivo gene transfer targeting key SR Ca2+ cycling proteins (ie, SERCA2a) provides a novel method for understanding the underlying mechanisms for the development of sudden cardiac death. More importantly, an understanding of these mechanisms combined with improved gene transfer techniques offer a novel strategy for arrhythmia therapy in humans.

Acknowledgments

We thank Michelle Jennings for assistance with data analysis.

Sources of Funding

This study was supported by National Institutes of Health grant RO1-HL54807 (D.S.R.) and Fellowship Awards from the Heart Rhythm Society and National Institutes of Health National Research Service (M.J.C.).

Disclosures

Dr Hajjar has significant ownership interest in Celladon and Nanocr.

References

  1. ↵
    Bers DM. Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda). 2006; 21: 380–387.
    OpenUrlAbstract/FREE Full Text
  2. Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, Curtis A, Fontaine J, Holmes D, Russo A, Tang C, Bigger JT Jr. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation. 2004; 110: 1885–1889.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Chudin E, Goldhaber JI, Weiss J, Kogan B. Intracellular Ca2 dynamics and the stability of ventricular tachycardia. Biophys J. 1999; 77: 2930–2941.
    OpenUrlCrossRefPubMed
  4. ↵
    Del Monte F, Hajjar RJ. Targeting calcium cycling proteins in heart failure through gene transfer. J Physiol (Lond). 2003; 546: 49–61.
    OpenUrlCrossRefPubMed
  5. ↵
    Del Monte F, Harding SE, Schmidt U, Matsui T, Kang ZB, Dec W, Gwathmey JK, Rosenzweig A, Hajjar RJ. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation. 1999; 100: 2308–2311
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Del Monte F, Lebeche D, Guerrero JL, Tsuji T, Doye AA, Gwathmey JK, Hajjar RJ. Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci U S A. 2004; 101: 5622–5627.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Diaz ME, O'Neill SC, Eisner DA. Sarcoplasmic reticulum calcium content fluctuation is the key to cardiac alternans. Circ Res. 2004; 94: 650–656.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Donahue JK, Heldman AW, Fraser H, McDonald AD, Miller JM, Rade JJ, Eschenhagen T, Marbán E. Focal modification of electrical conduction in the heart by viral gene transfer. Nature Med. 2000; 6: 1395–1398.
    OpenUrlCrossRefPubMed
  9. ↵
    Goldhaber JI, Xie LH, Duong T, Motter C, Khuu K, Weiss JN. Action potential duration restitution and alternans in rabbit ventricular myocytes: the key role of intracellular calcium cycling. Circ Res. 2005; 96: 459–466.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985; 260: 3440–3450.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Hirata Y, Kodama I, Iwamura N, Shimizu T, Toyama J, Yamada K. Effects of verapamil on canine Purkinje fibers and ventricular muscle fibers with particular reference to the alternation of action potential duration after a sudden increase in driving rate. Cardiovasc Res. 1979; 13: 1–8.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Hoffman BF, Suckling EE. Effect of heart rate on cardiac membrane potentials and unipolar electrogram. Am J Physiol. 1954; 179: 123–130.
    OpenUrlFREE Full Text
  13. ↵
    Hüser J, Wang YG, Sheehan KA, Cifuentes F, Lipsius SL, Blatter LA. Functional coupling between glycolysis and excitation-contraction coupling underlies alternans in cat heart cells. J Physiol (Lond). 2000; 524: 795–806.
    OpenUrlCrossRefPubMed
  14. Jaski BE, Hajjar RJ, Mancini DM, Cappola J, Pauly DF, Greenberg B, Yaroshinsky ARJ, Dittrich HBK, Zsebo KM, Jessup ML. Myocardial delivery of AAV1/SERCA2a in subjects with advanced heart failure: a first-in-human clinical trial [abstract]. Circulation. 2008; 118: S2314.
    OpenUrl
  15. ↵
    Kameyama M, Hirayama Y, Saitoh H, Maruyama M, Atarashi H, Takano T. Possible contribution of the sarcoplasmic reticulum Ca(2+) pump function to electrical and mechanical alternans. J Electrocardiol. 2003; 36: 125–135.
    OpenUrlCrossRefPubMed
  16. ↵
    Katra RP, Pruvot E, Laurita KR. Intracellular calcium handling heterogeneities in intact guinea pig hearts. Am J Physiol Heart Circ Physiol. 2004; 286: H648–H656.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Kleinfeld M, Stein E, Kossmann C. Electrical alternans with emphasis n recent observations made by means of single-cell electrical recording. Am Heart J. 1963; 65: 495–500.
    OpenUrlCrossRefPubMed
  18. ↵
    Konta T, Ikeda K, Yamaki M, Nakamura K, Honma K, Kubota I, Yasui S. Significance of discordant ST alternans in ventricular fibrillation. Circulation. 1990; 82: 2185–2189.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Laurita KR, Katra R, Wible B, Wan X, Koo MH. Transmural heterogeneity of calcium handling in canine. Circ Res. 2003; 92: 668–675.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Lehnart SE, Terrenoire C, Reiken S, Wehrens XH, Song LS, Tillman EJ, Mancarella S, Coromilas J, Lederer WJ, Kass RS, Marks AR. Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias. Proc Natl Acad Sci U S A. 2006; 103: 7906–7910.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Lukas A, Antzelevitch C. Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia: role of the transient outward current. Circulation. 1993; 88: 2903–2915.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Luo C, Rudy Y. A model of the ventricular cardiac action potential: depolarization, repolarization, and their interaction. Circ Res. 1991; 68: 1501–1526.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Murphy CF, Lab MJ, Horner SM, Dick DJ, Harrison FG. Regional electromechanical alternans in anesthetized pig hearts: modulation by mechanoelectric feedback. Am J Physiol. 1994; 267: H1726–H1735.
    OpenUrlPubMed
  24. ↵
    Pagel PS, Hettrick DA, Kersten JR, Warltier DC. Dexmedetomidine produces similar alterations in the determinants of left ventricular afterload in conscious dogs before and after the development of pacing-induced cardiomyopathy. Anesthesiology. 1998; 89: 741–748.
    OpenUrlCrossRefPubMed
  25. ↵
    Pastore JM, Girouard SD, Laurita KR, Akar FG, Rosenbaum DS. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation. 1999; 99: 1385–1394.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Pastore JM, Rosenbaum DS. Role of structural barriers in the mechanism of alternans-induced reentry. Circ Res. 2000; 87: 1157–1163.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Picht E, DeSantiago J, Blatter LA, Bers DM. Cardiac alternans do not rely on diastolic sarcoplasmic reticulum calcium content fluctuations. Circ Res. 2006; 99: 740–748.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Prunier F, Kawase Y, Gianni D, Scapin C, Danik SB, Ellinor PT, Hajjar RJ, Del Monte F. Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion. Circulation. 2008; 118: 614–624.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Pruvot EJ, Katra RP, Rosenbaum DS, Laurita KR. Role of calcium cycling versus restitution in the mechanism of repolarization alternans. Circ Res. 2004; 94: 1083–1090.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Qu Z, Garfinkel A, Chen P, Weiss J. Mechanisms of discordant alternans and induction of reentry in simulated cardiac tissue. Circulation. 2000; 102: 1664–1670.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Robertson BE, Corry PR, Nye PCG, Kozlowski RZ. Ca2+ and Mg-ATP activated potassium channels from rat pulmonary artery. Pflugers Arch. 1992; 421: 97–99.
    OpenUrlCrossRefPubMed
  32. ↵
    Rosenbaum DS, Akar FG. The Electrophysiologic substate for reentry: Unique insights from high-resolution optical mapping with voltage-sensitive dyes. In: Cabo C, Rosenbaum DS, eds. Quantitative Cardiac Electrophysiology. New York, NY: Marcel Dekker Inc; 2002: 555–582.
  33. ↵
    Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med. 1994; 330: 235–241.
    OpenUrlCrossRefPubMed
  34. ↵
    Saitoh H, Bailey J, Surawicz B. Alternans of action potential duration after abrupt shortening of cycle length: differences between dog Purkinje and ventricular muscle fibers. Circ Res. 1988; 62: 1027–1040.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Saitoh H, Bailey J, Surawicz B. Action potential duration alternans in dog Purkinje and ventricular muscle fibers. Circulation. 1989; 80: 1421–1431.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Saxon LA, Sherman CT, Stevenson WG, Yeatman LA, Wiener I. Ventricular tachycardia after infarction: sources of coronary blood flow to the infarct zone. Am Heart J. 1992; 124: 84–86.
    OpenUrlCrossRefPubMed
  37. ↵
    Schlotthauer K, Bers DM. Sarcoplasmic reticulum Ca2+ release causes myocyte depolarization: underlying mechanism and threshold for triggered action potentials. Circ Res. 2000; 87: 774–780.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Sheu WHH, Jeng C-Y, Shieh S-M, Fuh MMT, Shen DDC, Chen Y-DI, Reaven GM. Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am J Hypertens. 1992; 5: 444–448.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Shiferaw Y, Sato D, Karma A. Coupled dynamics of voltage and calcium in paced cardiac cells. Phys Rev E Stat Nonlin Soft Matter Phys. 2005; 71: 021903.
    OpenUrlPubMed
  40. ↵
    Surawicz B, Fisch C. Cardiac alternans: diverse mechanisms and clinical manifestations. J Am Coll Cardiol. 1992; 20: 483–499.
    OpenUrlCrossRefPubMed
  41. ↵
    Walker ML, Wan X, Kirsch GE, Rosenbaum DS. Hysteresis effect implicates calcium cycling as a mechanism of repolarization alternans. Circulation. 2003; 108: 2704–2709.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Wan X, Laurita KR, Pruvot E, Rosenbaum DS. Molecular correlates of repolarization alternans in cardiac myocytes. J Mol Cell Cardiol. 2005; 39: 419–428.
    OpenUrlCrossRefPubMed
  43. ↵
    Weiss JN, Karma A, Shiferaw Y, Chen PS, Garfinkel A, Qu Z. From pulsus to pulseless: the saga of cardiac alternans. Circ Res. 2006; 98: 1244–1253.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Xie LH, Sato D, Garfinkel A, Qu Z, Weiss JN. Intracellular Ca alternans: coordinated regulation by sarcoplasmic reticulum release, uptake, and leak. Biophys J. 2008; 95: 3100–3110.
    OpenUrlCrossRefPubMed

CLINICAL PERSPECTIVE

T-wave alternans arises from beat to beat alternans of cellular repolarization, is a consistent precursor to ventricular fibrillation in experimental animals, and is a recognized marker of risk for sudden cardiac death in patients. However, the molecular basis for cardiac alternans is poorly understood. Previously, we reported an association between deficient expression of SERCA2a, the protein responsible for calcium reuptake into sarcoplasmic reticulum, and resistance to alternation of calcium transients. In the present study, we demonstrated that targeted in vivo gene transfer of SERCA2a significantly suppresses cellular alternans in the intact heart and voltage-clamped myocytes isolated from these hearts. These findings provided definitive evidence for a primary role of intracellular calcium cycling in the mechanism of cardiac alternans. Moreover, SERCA2a gene transfer reduced susceptibility to inducible ventricular arrhythmias in the intact beating heart. Taken together, these data point to a novel molecular target for ameliorating cardiac electric instability, and suggest possible approaches for genetically engineering hearts that are resistant to ventricular arrhythmias.

Footnotes

  • Drs Cutler and Wan contributed equally to this work.

View Abstract

This Issue

Jump to

Article Tools

Share this Article

  • Email
  • Targeted SERCA2a Gene Expression Identifies Molecular Mechanism and Therapeutic Target for Arrhythmogenic Cardiac AlternansCLINICAL PERSPECTIVE
    Michael J. Cutler, Xiaoping Wan, Kenneth R. Laurita, Roger J. Hajjar and David S. Rosenbaum
    Circulation: Arrhythmia and Electrophysiology. 2009;2:686-694, originally published December 15, 2009
    https://doi.org/10.1161/CIRCEP.109.863118
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects